Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Canada
0
Australia
0
South Africa
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Antagonil
2. Cardene
3. Cardene I.v.
4. Cardene Sr
5. Dagan
6. Flusemide
7. Hydrochloride, Nicardipine
8. La, Nicardipine
9. Lecibral
10. Lincil
11. Loxen
12. Lucenfal
13. Nicardipine
14. Nicardipine La
15. Nicardipino Ratiopharm
16. Nicardipino Seid
17. Perdipine
18. Ridene
19. Vasonase
20. Y 93
21. Y-93
22. Y93
1. 54527-84-3
2. Nicardipine Hcl
3. Cardene
4. Perdipine
5. Loxen
6. Nicodel
7. Perdipina
8. Yc-93
9. Nicardipine (hydrochloride)
10. Dagan
11. Lecibral
12. Vasonase
13. Ridene
14. Yc-93 Hydrochloride
15. Nicardipinehydrochloride
16. Barizin
17. Cardepine
18. Dacarel
19. Lecibra
20. Lescodil
21. Nerdipina
22. Nicapress
23. Nicardal
24. Nicarpin
25. Nimicor
26. Rycarden
27. Vasodin
28. Nicant
29. Ranvil
30. Rydene
31. Rs-69216
32. Rs-69216-xx-07-0
33. Nsc-757855
34. Mls000069782
35. 2-(benzylmethylamino)ethyl Methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylatemonohydrochloride
36. Lincil
37. K5bc5011k3
38. Cardene Sr
39. 2-(benzylmethylamino)ethyl Methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate Monohydrochloride
40. 3-{2-[benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
41. Rs-69216xx07-0
42. Angioglebil
43. Bionicard
44. Nicardil
45. Smr000058487
46. Dafil
47. Cardene (tn)
48. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, Methyl 2-(methyl(phenylmethyl)amino)ethyl Ester, Monohydrochloride
49. 3-(2-(benzyl(methyl)amino)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
50. 5-o-[2-[benzyl(methyl)amino]ethyl] 3-o-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
51. Yc 93
52. Sr-01000075333
53. Einecs 259-198-4
54. Nicardipine Hydrochloride [usan:jan]
55. Nerdipine
56. Unii-k5bc5011k3
57. Ccris 8508
58. 69441-18-5
59. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl 5-(2-(methyl(phenylmethyl)amino)ethyl) Ester, Hydrochloride (1:1)
60. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl 5-[2-[methyl(phenylmethyl)amino]ethyl] Ester, Hydrochloride (1:1)
61. Prestwick_590
62. Einecs 274-007-4
63. Mfcd00057327
64. Opera_id_357
65. Cardene In 4.8% Dextrose In Plastic Container
66. Cardene In 5.0% Dextrose In Plastic Container
67. Cas-54527-84-3
68. Dsstox_cid_26992
69. Dsstox_rid_82040
70. Dsstox_gsid_46992
71. Schembl41845
72. 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)methyl-2-[methyl(phenylmethyl)amino]-3,5-pyridinedicarboxylic Acid Ethyl Ester Hydrochloride
73. Mls001146898
74. Mls002153279
75. Mls002153794
76. Nicardipine Hydrochloride,(s)
77. Spectrum1501135
78. Chebi:7551
79. Cardene In 0.83% Sodium Chloride In Plastic Container
80. Cardene In 0.86% Sodium Chloride In Plastic Container
81. Chembl1200326
82. Chembl3199626
83. Dtxsid9046992
84. Hms1569m07
85. Hms1921h21
86. Pharmakon1600-01501135
87. Bcp05610
88. Tox21_301832
89. Tox21_500809
90. Ccg-39033
91. Hy-12515a
92. Nsc757855
93. S4181
94. Tn-901
95. Nicardipine Hydrochloride [mi]
96. Akos015994734
97. Bcp9000988
98. Cs-3684
99. Ks-1276
100. Lp00809
101. Nc00578
102. Nicardipine Hydrochloride [jan]
103. Nsc 757855
104. Rs-69216-xx-07-o
105. Nicardipine Hydrochloride (jp17/usan)
106. Nicardipine Hydrochloride [usan]
107. Ncgc00094142-01
108. Ncgc00094142-02
109. Ncgc00094142-03
110. Ncgc00094142-04
111. Ncgc00094142-05
112. Ncgc00256289-01
113. Ncgc00261494-01
114. Nicardipine Hydrochloride [mart.]
115. Nicardipine Hydrochloride [vandf]
116. 2-(benzyl(methyl)amino)ethyl Methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate Hydrochloride
117. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-, 2-(benzylmethylamino)ethyl Methyl Ester, Monohydrochloride
118. Ac-36579
119. Nicardipine Hydrochloride [usp-rs]
120. Nicardipine Hydrochloride [who-dd]
121. Nicardipine Hydrochloride, Powder, >=98%
122. Db-052598
123. Eu-0100809
124. Ft-0630671
125. N0635
126. Sw196762-3
127. D00617
128. D91754
129. N 7510
130. Nicardipine Hydrochloride [ep Monograph]
131. Nicardipine Hydrochloride [orange Book]
132. Nicardipine Hydrochloride [usp Monograph]
133. 527n843
134. A830225
135. Sr-01000075333-1
136. Sr-01000075333-5
137. W-105615
138. Q27281986
139. 12-(7-nitrobenzofurazan-4-ylamino)dodecanoicacid
140. Nicardipine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
141. Nicardipine For System Suitability, European Pharmacopoeia (ep) Reference Standard
142. Nicardipine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
143. 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic Acid 3-(2-(n-benzyl-n-methylamino))-ethyl Ester 5-methyl Ester Hydrochloride
144. 2-(n-benzyl-n-methylamino)ethyl Methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
145. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,?methyl 2-[methyl(phenylmethyl)amino]ethyl Ester, Hydrochloride (1:1)
146. O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride;nicardipine Hcl
Molecular Weight | 516.0 g/mol |
---|---|
Molecular Formula | C26H30ClN3O6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 10 |
Exact Mass | 515.1823134 g/mol |
Monoisotopic Mass | 515.1823134 g/mol |
Topological Polar Surface Area | 114 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 856 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Cardene |
Drug Label | Cardene (nicardipine HCI) is a calcium ion influx inhibitor (slow channel blocker or calcium channel blocker). Cardene I.V. for intravenous administration contains 2.5 mg/mL of nicardipine hydrochloride. Nicardipine hydrochloride is a dihydropy... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Injectable; Capsule |
Route | Injection; Oral |
Strength | 25mg/10ml (2.5mg/ml); 30mg; 20mg |
Market Status | Prescription |
Company | Chiesi Usa |
2 of 6 | |
---|---|
Drug Name | Cardene sr |
Drug Label | CARDENE SR is a sustained release formulation of CARDENE. CARDENE SR capsules for oral administration each contain 30 mg, 45 mg or 60 mg of nicardipine hydrochloride. Nicardipine hydrochloride is a calcium ion influx inhibitor (slow channel block... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 60mg; 30mg |
Market Status | Prescription |
Company | Chiesi Usa |
3 of 6 | |
---|---|
Drug Name | Nicardipine hydrochloride |
PubMed Health | Nicardipine |
Drug Classes | Antianginal, Antihypertensive, Cardiovascular Agent |
Drug Label | Nicardipine hydrochloride capsules for oral administration each contain 20 mg or 30 mg of nicardipine hydrochloride. Nicardipine hydrochloride is a calcium ion influx inhibitor (slow channel blocker or calcium channel blocker).Nicardipine hydrochlori... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 30mg; 25mg/10ml (2.5mg/ml); 20mg |
Market Status | Prescription |
Company | Exela Pharma Science; Wockhardt; Navinta; Bedford; Ani Pharms; Epic Pharma; Sun Pharma Global; Mylan Institutional; Luitpold; Mylan |
4 of 6 | |
---|---|
Drug Name | Cardene |
Drug Label | Cardene (nicardipine HCI) is a calcium ion influx inhibitor (slow channel blocker or calcium channel blocker). Cardene I.V. for intravenous administration contains 2.5 mg/mL of nicardipine hydrochloride. Nicardipine hydrochloride is a dihydropy... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Injectable; Capsule |
Route | Injection; Oral |
Strength | 25mg/10ml (2.5mg/ml); 30mg; 20mg |
Market Status | Prescription |
Company | Chiesi Usa |
5 of 6 | |
---|---|
Drug Name | Cardene sr |
Drug Label | CARDENE SR is a sustained release formulation of CARDENE. CARDENE SR capsules for oral administration each contain 30 mg, 45 mg or 60 mg of nicardipine hydrochloride. Nicardipine hydrochloride is a calcium ion influx inhibitor (slow channel block... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 60mg; 30mg |
Market Status | Prescription |
Company | Chiesi Usa |
6 of 6 | |
---|---|
Drug Name | Nicardipine hydrochloride |
PubMed Health | Nicardipine |
Drug Classes | Antianginal, Antihypertensive, Cardiovascular Agent |
Drug Label | Nicardipine hydrochloride capsules for oral administration each contain 20 mg or 30 mg of nicardipine hydrochloride. Nicardipine hydrochloride is a calcium ion influx inhibitor (slow channel blocker or calcium channel blocker).Nicardipine hydrochlori... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 30mg; 25mg/10ml (2.5mg/ml); 20mg |
Market Status | Prescription |
Company | Exela Pharma Science; Wockhardt; Navinta; Bedford; Ani Pharms; Epic Pharma; Sun Pharma Global; Mylan Institutional; Luitpold; Mylan |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19552
Submission : 2006-06-26
Status : Active
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
NDC Package Code : 42765-046
Start Marketing Date : 2022-04-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-09-15
Pay. Date : 2022-08-26
DMF Number : 37287
Submission : 2022-08-28
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-02-08
Pay. Date : 2023-01-09
DMF Number : 37582
Submission : 2023-01-04
Status : Active
Type : II
NDC Package Code : 14501-0113
Start Marketing Date : 2022-12-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21211
Submission : 2007-12-31
Status : Active
Type : II
Date of Issue : 2019-07-22
Valid Till : 2022-07-21
Written Confirmation Number : WC-0075
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-09-28
Pay. Date : 2017-09-25
DMF Number : 10104
Submission : 1993-02-19
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-04-01
Pay. Date : 2024-02-21
DMF Number : 39326
Submission : 2024-01-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-11-13
Pay. Date : 2023-09-25
DMF Number : 38876
Submission : 2023-09-28
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?